Article info

Original research
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine

Authors

  1. Correspondence to Dr Mariaelena Pierobon; mpierobo{at}gmu.edu
View Full Text

Citation

Baldelli E, Hodge KA, Bellezza G, et al
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine

Publication history

  • Accepted September 20, 2021
  • First published October 7, 2021.
Online issue publication 
October 07, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.